“loxo-oncology” Archives

in
Entry Author Date Location
Elevation Oncology Debuts With $32.5M to Develop Targeted Cancer Drugs 07/21/20 New York
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic 01/07/20 Boston
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Colorectal Cancer Data Spurs Pfizer to Pay $11.4B for Array Bio 06/17/19 Boulder/Denver
ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight 05/16/19 National
Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs 03/22/19 San Diego
Bayer Snaps Up Rights to Two Cancer Drugs from Lilly’s $8B Loxo Deal 02/15/19 Indiana
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer 01/18/19 National
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More 01/11/19 National
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Eli Lilly Makes an $8B Cancer Genetics Bet with Loxo Acquisition 01/07/19 Indiana
Genetic Medicine: FDA OKs 2nd Cancer Drug That Targets DNA, Not Tissues 11/26/18 National
Tocagen Appoints Lori Kunkel as Acting Chief Medical Officer 11/16/18 San Diego
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front 10/23/18 National
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
Another Precision Step for Roche as Ignyta Drug Heads to Regulators 09/24/18 San Francisco
ASCO Wrap: Cancer Combos, Precision Meds, Stock Movers & More 06/05/18 National
Loxo Unveils More Data, Paves a Path Forward In Precision Oncology 06/02/18 National
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More 06/01/18 National
Drugs OK’d To Hit Tumor Genes Still a Basket of One. Are More Coming? 05/31/18 National
Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout 05/18/18 National
Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts 04/13/18 National
CMS Starts to Cover Broad Cancer DNA Tests, Boosting Foundation, Thermo 03/19/18 Boston
Trump v. Drug Makers? And 6 More Burning Biopharma Questions for 2018 01/02/18 National
Roche Bets $1.7B More on Precision Oncology With Ignyta Deal 12/22/17 San Diego
Bio Roundup: Tax Cuts, Drug Approval Record, New Flagship Cash & More 12/22/17 National
Will Foundation’s FDA, CMS Nod Help Cancer DNA Tests Break Through? 12/01/17 Boston
In a Precision Step, Bayer Writes Loxo $400M Check for Two Cancer Drugs 11/14/17 New York
Page 1 of 2 next page »